Literature DB >> 20004787

Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses.

Calman Prussin1, Joohee Lee, Barbara Foster.   

Abstract

BACKGROUND: Both anaphylactic food allergy and eosinophil-associated gastrointestinal disorders are associated with T(H)2 responses and food-specific IgE, yet they have very different clinical presentations.
OBJECTIVE: To determine whether the clinical differences between anaphylactic food allergy and eosinophil-associated gastrointestinal disorders are reflected in different T(H)2 responses to foods.
METHODS: Subjects with peanut allergy (PA), subjects with allergic eosinophilic gastroenteritis (AEG), and nonatopic subjects were enrolled. Antigen-specific IL-4, IL-5, IFN-gamma, and TNF T-cell responses to peanut, soy, and shrimp were measured by using intracellular cytokine staining and polychromatic flow cytometry.
RESULTS: Two distinct subpopulations of T(H)2 cells were found: IL-5+ T(H)2 (IL-4+, IL-5+) and IL-5(-) T(H)2 (IL-4+, IL-5(-)) cells. Peanut-specific IL-5+ T(H)2 cells were present at a 20-fold greater frequency in AEG versus PA (81 vs 4 per 10(6) CD4 cells; P = .05), whereas there were similar frequencies of IL-5(-) T(H)2 cells (67 vs 41 per 10(6)). For all foods, IL-5+ T(H)2 cells accounted for a significantly greater fraction of the antigen-specific cells in AEG relative to PA (29% vs 4%; P < .0001). In PA but not AEG, IL-5(-) T(H)2 responses to peanut were highly correlated with peanut-specific IgE (r = 0.87 vs 0.55, respectively). All subject groups elicited similar very low-magnitude T(H)1 responses to food antigens.
CONCLUSION: T(H)2 responses are composed of 2 subpopulations: IL-5+ T(H)2 and IL-5(-) T(H)2 cells. IL-5+ T(H)2 food allergen-specific T cells are singularly associated with AEG, whereas PA is associated with a dominant IL-5(-) T(H)2 response. These results suggest heterogeneity within the T(H)2 cytokine response, with different T(H)2 responses alternatively favoring IgE-mediated or eosinophil-dominant immunopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004787      PMCID: PMC2994258          DOI: 10.1016/j.jaci.2009.09.048

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.

Authors:  A Straumann; M Bauer; B Fischer; K Blaser; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

2.  Eosinophilic esophagitis: a 10-year experience in 381 children.

Authors:  Chris A Liacouras; Jonathan M Spergel; Eduardo Ruchelli; Ritu Verma; Maria Mascarenhas; Edisio Semeao; Jonathan Flick; Janice Kelly; Terry Brown-Whitehorn; Petar Mamula; Jonathan E Markowitz
Journal:  Clin Gastroenterol Hepatol       Date:  2005-12       Impact factor: 11.382

3.  Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression.

Authors:  Tina B Thottingal; Bill P Stefura; F Estelle R Simons; Gary A Bannon; Wesley Burks; Kent T HayGlass
Journal:  J Allergy Clin Immunol       Date:  2006-08-24       Impact factor: 10.793

4.  Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13.

Authors:  Liying Guo; Jane Hu-Li; William E Paul
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

Review 5.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

6.  Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis.

Authors:  J S Jaffe; S P James; G E Mullins; L Braun-Elwert; I Lubensky; D D Metcalfe
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

7.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 8.  Food allergy: recent advances in pathophysiology and treatment.

Authors:  Scott H Sicherer; Hugh A Sampson
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

9.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.

Authors:  Mübeccel Akdis; Johan Verhagen; Alison Taylor; Fariba Karamloo; Christian Karagiannidis; Reto Crameri; Sarah Thunberg; Günnur Deniz; Rudolf Valenta; Helmut Fiebig; Christian Kegel; Rainer Disch; Carsten B Schmidt-Weber; Kurt Blaser; Cezmi A Akdis
Journal:  J Exp Med       Date:  2004-06-01       Impact factor: 14.307

View more
  51 in total

1.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

Review 2.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

3.  Two Cases of Eosinophilic Gastroenteritis With Rare Manifestations Revealed in Medical Checkup Findings.

Authors:  Tsuyoshi Mishiro; Mamiko Nagase; Makoto Nagasaki; Kyoichi Adachi; Shunji Ishihara
Journal:  Cureus       Date:  2020-12-17

4.  Systemic innate immune activation in food protein-induced enterocolitis syndrome.

Authors:  Ritobrata Goswami; Ana Belen Blazquez; Roman Kosoy; Adeeb Rahman; Anna Nowak-Węgrzyn; M Cecilia Berin
Journal:  J Allergy Clin Immunol       Date:  2017-02-10       Impact factor: 10.793

5.  Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsets.

Authors:  David Chiang; Xintong Chen; Stacie M Jones; Robert A Wood; Scott H Sicherer; A Wesley Burks; Donald Y M Leung; Charuta Agashe; Alexander Grishin; Peter Dawson; Wendy F Davidson; Leah Newman; Robert Sebra; Miriam Merad; Hugh A Sampson; Bojan Losic; M Cecilia Berin
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793

Review 6.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 7.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

8.  Eosinophilic gastroenteritis and related eosinophilic disorders.

Authors:  Calman Prussin
Journal:  Gastroenterol Clin North Am       Date:  2014-06       Impact factor: 3.806

Review 9.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

10.  Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis.

Authors:  Yoshikazu Kinoshita; Kenji Furuta; Norihisa Ishimaura; Shunji Ishihara; Shuichi Sato; Riruke Maruyama; Shuichi Ohara; Takayuki Matsumoto; Choitsu Sakamoto; Toshiyuki Matsui; Satoshi Ishikawa; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.